The finding on MD-induced Akt and JNK activation is in line with previous studies conducted in various cancer cell lines, while transient Akt phosphorylation, followed by its strong inhibition, and robust JNK activation in AA+MD-treated GBM cells, is demonstrated here for the first time [56,57]. The gene discussed is AKT1; the disease is cancer.